Reasons to Question Psychologist Prescribing

Seppa N . Prescribing pursuits build momentum. APA Monitor 1996;27:32–3.

DeLeon PH Sammons MT Sexton JL . Focusing on society's real needs: Responsibility and prescription privileges? Am Psychol 1995;50:1022–32.

Hayes SC Heiby E . Psychology's drug problem: Do we need a fix or should we just say no? Am Psychol 1996;51:198–206.

DeNelsky GY . The case against prescription privileges for psychologists. Am Psychol 1996;51:207–12.

Manasse HR Jr. Medication use in an imperfect world: Drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 1989;46:929–44.

Manasse HR Jr. Medication use in an imperfect world: Drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm 1989;46:1141–52.

Classen DC Pestotnik SL Evans S Lloyd JF Burke JP . Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301–6.

Cohen LJ Guthrie SK . Depression in primary care: Review of AHCPR guidelines. Ann Pharmacother 1997;31:782–5.

Clinical practice guideline. Number 5. Depression in primary care. US Department of Health and Human Services, Agency for Health Care Policy and Research. Washington, DC: US Government Printing Office, 1993, publication no. 93–0550, 93–0551.

DeLeon PH Wiggins JG . Prescription privileges for psychologists. Am Psychol 1996;51:225–9.

Caroff SN . The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79–83.